What You Missed:

Hear Keynote Presentations Outlining the Current Landscape and Late-Breaking Case-Studies from Degradation Leaders with presentations from Nurix, Proxygen & Amphista Therapeutics

Learn and Overcome the Challenges towards an Improved the Safety Profile of PROTACs and Progress Your Candidates into the Clinic with presentations from AstraZeneca & Bayer

Review the Next Generation Advances PROTAC, Molecular Glues and Combination Therapies Across Different Therapeutic Indications with presentations from Sibylla Biotech, Kymera & Mission Therapeutics

Consider How to Optimise Degrader Design via Enhanced Assay Selection and Development and Boost Degrader Translation with presentations from Technical University Darmstadt & AstraZeneca

Deep-Dive into the Progress within Computational Modelling of TPD toward an Improved Structural Prediction and Understanding of Selectivity with presentations from Celeris Therapeutics, Aelin Therapeutics & Nurix Therapeutics